ostx

Latest Posts

OS Therapies (NYSE: OSTX) is a most cancers immunotherapy firm engaged within the improvement...

Market

OS Therapies is actively advancing its osteosarcoma immunotherapy: CEO Paul Romness | AlphaStreet